These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 18635284

  • 41. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
    Tixier F, Vriens D, Cheze-Le Rest C, Hatt M, Disselhorst JA, Oyen WJ, de Geus-Oei LF, Visser EP, Visvikis D.
    J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
    [Abstract] [Full Text] [Related]

  • 42. Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
    Nambu A, Kato S, Motosugi U, Araki T, Okuwaki H, Nishikawa K, Saito A, Matsumoto K, Ichikawa T.
    Eur J Radiol; 2010 Mar; 73(3):510-7. PubMed ID: 19246170
    [Abstract] [Full Text] [Related]

  • 43. Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.
    Li M, Sun Y, Liu Y, Han A, Zhao S, Ma L, Zheng J, Yu J.
    Lung Cancer; 2010 Jun; 68(3):394-7. PubMed ID: 19683358
    [Abstract] [Full Text] [Related]

  • 44. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 45. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.
    Lim CH, Ahn TR, Moon SH, Cho YS, Choi JY, Kim BT, Lee KH.
    Eur Radiol; 2019 Apr; 29(4):1903-1911. PubMed ID: 30315418
    [Abstract] [Full Text] [Related]

  • 46. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
    Gómez-Caro A, Garcia S, Reguart N, Arguis P, Sanchez M, Gimferrer JM, Marrades R, Lomeña F.
    Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
    [Abstract] [Full Text] [Related]

  • 47. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
    Sahiner I, Atasever T, Akdemir UO, Ozturk C, Memis L.
    Rev Esp Med Nucl Imagen Mol; 2013 May; 32(6):357-63. PubMed ID: 23747221
    [Abstract] [Full Text] [Related]

  • 48. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
    Casiraghi M, Travaini LL, Maisonneuve P, Tessitore A, Brambilla D, Agoglia BG, Guarize J, Spaggiari L.
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
    Vural GU, Akkas BE, Demirel BB.
    Rev Esp Med Nucl Imagen Mol; 2014 Apr; 33(5):268-73. PubMed ID: 25018135
    [Abstract] [Full Text] [Related]

  • 51. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M, Ichiguchi O.
    Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. GLUT1 expression in tissue and (18)F-FDG uptake.
    Avril N.
    J Nucl Med; 2004 Jun; 45(6):930-2. PubMed ID: 15181126
    [No Abstract] [Full Text] [Related]

  • 58. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
    Akhurst T.
    J Surg Oncol; 2006 Dec 01; 94(7):547-8. PubMed ID: 17111390
    [No Abstract] [Full Text] [Related]

  • 59. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
    Lee HY, Chung JK, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC.
    Ann Nucl Med; 2008 May 01; 22(4):281-6. PubMed ID: 18535878
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.